U.S. Physical Therapy's declining ROCE trend is concerning. Despite reinvestment, returns are shrinking and shareholder returns have been flat over five years. The stock doesn't show multi-bagger traits, suggesting investors may find better options elsewhere.

Investors remain optimistic about U.S. Physical Therapy's robust earnings outlook. The market's high P/E ratio reflects strong future growth expectations for the company, despite the industry average.

The cautious investor sentiment towards the company's future is reflected in declining share price and EPS. A potential stabilization is indicated by a 0.7% TSR gain over past year, albeit below market return.